Neuralink Corp., Elon Musk’s brain-implant company, said it received approval from the US Food and Drug Administration to conduct human clinical trials.

“This is the result of incredible work by the Neuralink team in close collaboration with the FDA and represents an important first step that will one day allow our technology to help many people,” the company said in a tweet.